Age Impacts Surgical Outcomes for Breast Reconstruction
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Dec. 27, 2024 -- For patients undergoing breast reconstruction after mastectomy, age impacts surgical outcomes, with older age negatively correlated with the Satisfaction with Breasts domain of the BREAST-Q, but positively correlated with Psychosocial Well-Being, according to a study published in the January issue of Plastic and Reconstructive Surgery.
Minji Kim, from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a retrospective analysis of patients who underwent autologous (ABR) or implant-based breast reconstruction (IBR) after mastectomy to examine the impact of age on complications and patient-reported outcomes (PROs) measured preoperatively, at six months, and at one to five years postoperatively.
The study included 4,730 patients: 32.5 and 67.5 percent underwent ABR and IBR, respectively. The researchers observed a significant association for older age with an increased risk for developing mastectomy skin flap/nipple necrosis, infection, and seroma. A negative correlation was seen for older age with the Satisfaction with Breasts domain of the BREAST-Q, while a positive correlation was seen with the Psychosocial Well-Being domain. There was no correlation observed for older age with the Physical Well-Being of the Chest or Sexual Well-Being domains. Different complications and PRO profiles were seen in subgroup analyses of ABR and IBR patients.
"Older patients should be informed about the potential associated risks and anticipated PROs," the authors write. "Surgeons and patients can also use our findings to optimize older patients' postoperative satisfaction."
Authors disclosed ties to RTI Surgical, MirrorMe3D, Pfizer, Regeneron, Atyr, Integra, and PureTech.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-28 12:00
Read more
- Study: Blood Transfusion Post-Heart Attack May Be Critical for Those with Anemia
- FDA Approves Tryngolza (olezarsen) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome
- American Seniors Struggle to Pay Medical Bills More Than Peers in Other Wealthy Countries
- Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated Patients With Diffuse Large B-Cell Lymphoma
- Feeling 'Techno-Strain' From Work? You're Not Alone
- Children With Primary Ciliary Dyskinesia Likely to Have Asthma
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions